Bioharvest Sciences Stock Profit Margin
| CNVCF Stock | USD 5.13 0.07 1.35% |
Bioharvest Sciences fundamentals help investors to digest information that contributes to Bioharvest Sciences' financial success or failures. It also enables traders to predict the movement of Bioharvest OTC Stock. The fundamental analysis module provides a way to measure Bioharvest Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bioharvest Sciences otc stock.
Bioharvest |
Bioharvest Sciences OTC Stock Profit Margin Analysis
Bioharvest Sciences' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Bioharvest Sciences Profit Margin | (2.69) % |
Most of Bioharvest Sciences' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioharvest Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Bioharvest Sciences has a Profit Margin of -2.6911%. This is 75.99% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 111.9% higher than that of the company.
Bioharvest Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bioharvest Sciences' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Bioharvest Sciences could also be used in its relative valuation, which is a method of valuing Bioharvest Sciences by comparing valuation metrics of similar companies.Bioharvest Sciences is currently under evaluation in profit margin category among its peers.
Bioharvest Fundamentals
| Return On Equity | -63.64 | |||
| Return On Asset | -0.53 | |||
| Profit Margin | (2.69) % | |||
| Operating Margin | (2.45) % | |||
| Current Valuation | 106.97 M | |||
| Shares Outstanding | 460.72 M | |||
| Shares Owned By Insiders | 35.15 % | |||
| Price To Book | 91.96 X | |||
| Price To Sales | 28.13 X | |||
| Revenue | 2.1 M | |||
| Gross Profit | 670 K | |||
| EBITDA | (8.63 M) | |||
| Net Income | (9.83 M) | |||
| Cash And Equivalents | 1.21 M | |||
| Total Debt | 3.97 M | |||
| Debt To Equity | 1.62 % | |||
| Current Ratio | 0.69 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (6.79 M) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 1.02 | |||
| Market Capitalization | 75.88 M | |||
| Total Asset | 10.21 M | |||
| Z Score | 11.4 | |||
| Net Asset | 10.21 M |
About Bioharvest Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bioharvest Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioharvest Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioharvest Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Bioharvest OTC Stock
Bioharvest Sciences financial ratios help investors to determine whether Bioharvest OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioharvest with respect to the benefits of owning Bioharvest Sciences security.